NSPR vs RTX · rev $7.0M vs P/E 36, rev $88.60B
InspireMD Inc (NSPR) versus RTX Corporation (RTX) — a side-by-side from cached financials, not a winner call.
InspireMD Inc (NSPR) is a medical devices company listed on NASDAQ.
RTX Corporation (RTX) is a aerospace & defense company listed on NYSE. It is led by Chris Calio.
Latest reported NSPR revenue for 2024-12-31 was $7.0M. Net income was -$32.0M. Revenue was up 13.0% from 2023-12-31 to 2024-12-31. NSPR currently screens at market cap $34.6M.
Latest reported RTX revenue for 2025-12-31 was $88.60B. Net income was $6.73B. Revenue was up 9.7% from 2024-12-31 to 2025-12-31. RTX currently screens at market cap $259.34B and trailing P/E 36.2.
NSPR currently screens at market cap $34.6M. RTX currently screens at market cap $259.34B and trailing P/E 36.2.
Not investment advice. Open the NSPR and RTX stock pages for the full models.
Not investment advice.